Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/1997
08/19/1997US5658770 Nucleic acid sequence and plasmids comprising at least one phage resistance mechanism, bacteria in which they are present, and their use
08/19/1997US5658764 Method for determining whether an individual is a carrier for or afflicted with a fragile x mutation
08/19/1997US5658763 Methods and compositions for high protein production from non-native DNA
08/19/1997US5658762 DNA molecules, expression vectors and host cells expressing antigenized antibodies
08/19/1997US5658761 Cells remain adherent after irradiation which arrests cell growth and express simian virus 40 large t antigen
08/19/1997US5658760 Heteropolymeric protein production methods
08/19/1997US5658759 Expression vectors containing promoter, enhancer, 5'-untranslated region of major immediate early gene of human cytomegalovirus
08/19/1997US5658758 Human polypeptide
08/19/1997US5658756 CDNA encoding a novel human protein tyrosine phosphatase
08/19/1997US5658754 Cell-free synthesis and isolation of novel genes and polypeptides
08/19/1997US5658752 Contacting reactant with monoclonal antibody to form complex, reacting complex, releasing product
08/19/1997US5658748 Bioluminescent strain for determination of bacteriophages and antibiotics
08/19/1997US5658746 Cell surface receptor complementation
08/19/1997US5658742 Monoclonal antibody
08/19/1997US5658738 Bi-directional oligonucleotides that bind thrombin
08/19/1997US5658737 Compositions and methods for the simultaneous detection and quantification of multiple specific nucleic acid sequences
08/19/1997US5658729 Method, reagent and kit for evaluating susceptibility to premature atherosclerosis
08/19/1997US5658727 Filamentous phage encapsulating genome encoding ligand-binding antibody comprising first and second polypeptides where first polypeptide is fused to carboxy terminal phage membrane anchor domain
08/19/1997US5658724 Herpes simplex virus strains deficient for the essential immediate early genes ICP4 and ICP27 and methods for their production, growth and use
08/19/1997US5658568 Cytotoxic drug therapy
08/19/1997US5658567 Recombinant glycosylated biologically active human alpha-galactosidase a obtained by culturing host cell comprising recombinant baculovirus comprising nucleic acid encoding said enzyme, recovering
08/19/1997US5658565 Encoding of protein by nucleic acid transferred to cells in vascular occlusion site; drug delivery
08/19/1997US5658563 Insecticidally effective peptides
08/19/1997US5658548 Nucleic acid purification on silica gel and glass mixtures
08/19/1997CA1339307C Oral immunization by transgenic plants
08/19/1997CA1339305C Production of human somatomedin c
08/19/1997CA1339304C Template-directed photoligation
08/19/1997CA1339299C Human manganese superoxide dismutase dna; its expression; method of recovering human manganese superoxide dismutase, human manganese superoxide dismutase analogs or human manganese superoxide dismutase mutants; uses;compositions; and methods of treatment
08/14/1997WO1997029319A2 Bioluminescent novelty items
08/14/1997WO1997029213A1 Coding sequences of the human brca1 gene
08/14/1997WO1997029211A1 RESTRICTION DISPLAY (RD-PCR) OF DIFFERENTIALLY EXPRESSED mRNAs
08/14/1997WO1997029210A2 Fluorescence detection assay for homogeneous pcr hybridization systems
08/14/1997WO1997029202A1 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells
08/14/1997WO1997029201A2 Retroviral vector for the gene transfer of an il6 antagonist in human haematopoietic stem cells
08/14/1997WO1997029200A1 Cassettes for the expression of storable proteins in plants
08/14/1997WO1997029199A2 Prostate specific antigen peptides and uses thereof
08/14/1997WO1997029198A1 Thrombin muteins as antidotes for thrombin inhibitors
08/14/1997WO1997029197A1 Polypeptides having mutanase activity and nucleic acids encoding same
08/14/1997WO1997029196A1 Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy
08/14/1997WO1997029195A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
08/14/1997WO1997029194A2 Preparation of l-ascorbic acid
08/14/1997WO1997029193A1 Genomic ppo clones
08/14/1997WO1997029192A1 Mammalian dendritic cell chemokine reagents
08/14/1997WO1997029190A1 Method of plasmid dna production and purification
08/14/1997WO1997029187A1 Transaminases and aminotransferases
08/14/1997WO1997029186A1 Modification of polysaccharides
08/14/1997WO1997029185A1 Recombinant phages
08/14/1997WO1997029183A2 Methods and compositions for transforming dendritic cells and activating t cells
08/14/1997WO1997029180A1 Diabetes therapy
08/14/1997WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a)
08/14/1997WO1997029127A1 Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs
08/14/1997WO1997029124A1 Vitamin d response element binding protein
08/14/1997WO1997029123A2 Nucleic acid encoding gai gene of arabidopsis thaliana
08/14/1997WO1997029119A1 Fhit proteins and nucleic acids and methods based thereon
08/14/1997WO1997029113A2 Process for preparing purified nucleic acid and the use thereof
08/14/1997WO1997028824A1 Obesity protein compounds and formulations thereof
08/14/1997WO1997028818A1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
08/14/1997WO1997028817A1 Receptor ligand-facilitated delivery of biologically active molecules
08/14/1997WO1997028688A1 Intracellular vitamin d binding protein
08/14/1997WO1997022694A3 Diagnostic reagents relating to diabetes
08/14/1997WO1997008344A3 Method for identification of mutations using ligation of multiple oligonucleotide probes
08/14/1997DE19704979A1 Retroviral vector for expressing interleukin-6 antagonist in human haematopoietic stem cells
08/14/1997DE19605175A1 Lipidverbindungen und deren Verwendung Lipid compounds and their use
08/14/1997DE19605126A1 Thrombinmuteine als Antidot für Thrombininhibitoren Thrombin muteins as an antidote for thrombin inhibitors
08/14/1997DE19605105A1 Neue Sonde zur Früherkennung von epithelialen Dysplasien des mehrschichtigen Plattenepithels sowie zur Tumordiagnostik und Tumortherapie von Plattenepithelkarzinomen New probe for early detection of epithelial dysplasia of the stratified squamous epithelium as well as for tumor diagnosis and tumor therapy of squamous cell carcinoma
08/14/1997DE19604798A1 Herstellung von L-Ascorbinsäure Preparation of L-ascorbic acid
08/14/1997DE19604588A1 Cassette for expressing storage-stable proteins in plants
08/14/1997CA2733866A1 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
08/14/1997CA2246243A1 Transaminases and aminotransferases
08/14/1997CA2246242A1 Cassettes for the expression of storable proteins in plants
08/14/1997CA2245960A1 Vitamin d response element binding protein
08/14/1997CA2245849A1 Polypeptides having mutanase activity and nucleic acids encoding same
08/14/1997CA2245783A1 Fhit proteins and nucleic acids and methods based thereon
08/14/1997CA2245681A1 Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs
08/14/1997CA2245650A1 Intracellular vitamin d binding protein
08/14/1997CA2245546A1 Thrombin muteins as antidotes for thrombin inhibitors
08/14/1997CA2245508A1 Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy
08/14/1997CA2245170A1 Methods and compositions for transforming dendritic cells and activating t cells
08/14/1997CA2244812A1 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells
08/14/1997CA2244792A1 Recombinant phages
08/14/1997CA2244110A1 Novel methods of vaccination and vaccines thereof comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
08/14/1997CA2243718A1 Diabetes therapy
08/13/1997EP0789078A2 Engineered peptide synthetases and their use for the non-ribosomal production of peptides
08/13/1997EP0789077A1 Viral material and nucleotide fragments associated with multiple sclerose having diagnostic, prophylactic and therapeutical uses
08/13/1997EP0789076A2 G protein coupled receptor proteins, their production and use
08/13/1997EP0789073A2 Production of tryptophan by the bacterium Escherichia coli
08/13/1997EP0789032A2 Method for preparing a monoclonal antibody that provides an equimolar response to free and complexed analyte in a monoclonal/polyclonal sandwich immunoassay
08/13/1997EP0789031A2 Acellular vaccine
08/13/1997EP0788735A1 Potato plant, tuben, seed and microtuber genetically engineered to form amylopectin-type starch
08/13/1997EP0788557A1 Rapid detection and identification of nucleic acid variants and pathogens
08/13/1997EP0788556A1 New polynucleic acid sequences for use in the detection and differentiation of prokaryotic organisms
08/13/1997EP0788555A1 Methods of analysis and manipulation of dna utilizing mismatch repair systems
08/13/1997EP0788550A2 Process for protein production in plants
08/13/1997EP0788549A1 Regulatory nucleic acid sequences and uses thereof
08/13/1997EP0788548A1 Proteins having glycosyltransferase activity
08/13/1997EP0788547A2 Purified coprinus laccases and nucleic acids encoding same
08/13/1997EP0788546A1 Nematode-extracted serine protease inhibitors and anticoagulant proteins
08/13/1997EP0788545A2 Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
08/13/1997EP0788544A2 Recombinant dna
08/13/1997EP0788543A1 Alk-7 (activin like kinase), a serine threonine kinase receptor